Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients (Q33698128)

28 July 2017

title

Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients (English)

1 reference

28 July 2017

1 reference

1 reference

ChunHua Xu

1

1 reference

28 July 2017

LiKe Yu

series ordinal

2

1 reference

28 July 2017

Ping Zhan

series ordinal

3

1 reference

28 July 2017

Yu Zhang

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

European Journal of Medical Research

28 July 2017

published in

1 reference

28 July 2017

volume

19

1 reference

28 July 2017

page(s)

23

1 reference

Diagnostic molecular biomarkers for malignant pleural effusions.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

CD39+Regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

TH17 cells in development: an updated view of their molecular identity and genetic programming

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Diagnosis and management of malignant pleural effusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Increased frequencies of T helper type 17 cells in tuberculous pleural effusion

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Generation and Differentiation of IL-17–Producing CD4+ T Cells in Malignant Pleural Effusion

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Comparison of six biological markers for the diagnosis of tuberculous pleuritis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Diagnostic significance of interferon-gamma in tuberculous pleural effusions

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041345

CD4+CD25+ regulatory T lymphocytes in tuberculous pleural effusion

30 October 2018

1 reference

12 December 2020

T lymphocytes in pleural effusion

1 reference

12 December 2020

Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion

1 reference

12 December 2020

High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

1 reference

12 December 2020

Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

1 reference

12 December 2020

Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer

1 reference

12 December 2020

Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/2047-783X-19-23

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference